CORE LABORATORIES N V·4

Jan 3, 4:09 PM ET

Elvig Mark F 4

4 · CORE LABORATORIES N V · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2019-12-31
Elvig Mark F
VP, Counsel & Secretary
Transactions
  • Exercise/Conversion

    Performance Shares

    2019-12-312,4000 total
    Exercise: $0.00Common Shares (2,400 underlying)
  • Other

    Common Shares

    2019-12-311,10011,952 total
  • Sale

    Common Shares

    2020-01-02$37.94/sh100$3,79411,535 total
  • Other

    Common Shares

    2019-12-3113,67110,652 total
  • Tax Payment

    Common Shares

    2019-12-31$37.67/sh317$11,94111,635 total
  • Exercise/Conversion

    Common Shares

    2019-12-31+2,40013,052 total
  • Sale

    Common Shares

    2020-01-02$37.93/sh500$18,96511,035 total
Holdings
  • Common Shares

    (indirect: By 401(k))
    2,568
Footnotes (3)
  • [F1]Mr. Elvig transferred 13,671 shares to his former spouse pursuant to a divorce settlement that was effective October 4, 2019.
  • [F2]Mr. Elvig transferred 1,100 shares to his former spouse pursuant to a divorce settlement.
  • [F3]These awards vested at the end of a three-year performance period that began on January 1, 2017 and ended December 31, 2019 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION